Literature DB >> 16117334

Prognostic value of refined Wiberg's angle in hip development.

Anton Tudor1, Legović Dalen, Rubinić Dugan, Prpić Tomislav, Salamon Ratko.   

Abstract

There are many angles measured on hip radiographs, but their prognostic value for hip development in patient with DDH is controversial. Our aim was to find out how the development of congenitally luxated hip could be predicted after reduction using Wiberg's CE angle and CE angle refined according to Ogata. 119 hips of 61 patients were retrospectively evaluated after reduction from 3 months of age until at least full osteomaturity. According to results of CE angles measurements good and poor hip development group were formed. Healthy hips of the patients with unilateral DDH were considered to be the control group. Negative linear trend of the curve connecting Wiberg's CE angle values measured within first postreductive years is a poor prognostic sign of hip development as are absolute negative values of refined CE angles. In cases where negative initial refined CE angles are combined with negative linear trend of Wiberg's CE angles prognosis is extremely poor. Both Wiberg's and Ogata's CE angle are of prognostic value regarding hip development and should be measured when evaluating AP radiographs of infant's hip.

Entities:  

Mesh:

Year:  2005        PMID: 16117334

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  2 in total

1.  Developmental dysplasia of the hip - angle trends after operation in different age groups.

Authors:  Sonja Milasinovic; Radivoj Brdar; Ivana Petronic; Dejan Nikolic; Dragana Cirovic
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

2.  The lateral center-edge angle as radiographic selection criteria for periacetabular osteotomy for developmental dysplasia of the hip in patients aged above 13 years.

Authors:  Daguang Zhang; Xin Pan; Hong Zhang; Dianzhong Luo; Hui Cheng; Kai Xiao
Journal:  BMC Musculoskelet Disord       Date:  2020-07-25       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.